Michael Chi - 15 Sep 2026 Form 4 Insider Report for Hims & Hers Health, Inc. (HIMS)

Reporting relationship: Chief Operating Officer
Issuer ticker: HIMS
Reported as of: 15 Sep 2026
Net transaction value: -$398,227
SEC form: 4
Accepted by SEC: 17 Sep 2026, 16:17:21 UTC
Prior SEC filing: 18 Aug 2026
Source filing: View source filing
Reporting owner signature: /s/ Kimberly Mather, Attorney-in-Fact for Michael Chi

Key filing fact

Michael Chi filed Form 4 for Hims & Hers Health, Inc. (HIMS) on 17 Sep 2026.

Key facts

This page summarizes Michael Chi's Form 4 filing for Hims & Hers Health, Inc. (HIMS).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 17 Sep 2026, 16:17.

Change

Previous filing in this sequence was filed on 18 Aug 2026.
Current net transaction value: -$398,227.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001965903 Primary reporting owner

Chi Michael

Relationship: Chief Operating Officer
Address: 2269 CHESTNUT STREET, #523, SAN FRANCISCO
Signature: /s/ Kimberly Mather, Attorney-in-Fact for Michael Chi
Signature date: 17 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HIMS transaction

Class A Common Stock

Sale

Transaction value: $398,227
Shares: -14,027
Change %: -3%
Price: $28.39
Shares after: 456,660
Date: 15 Sep 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 1 footnote

Footnote F1

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 1, 2025 by the Reporting Person.